<DOC>
	<DOCNO>NCT01302002</DOCNO>
	<brief_summary>The study test metformin patient early breast cancer . Blood tissue collect use metformin .</brief_summary>
	<brief_title>The Use Metformin Early Breast Cancer Patients Pre-Surgery</brief_title>
	<detailed_description>Patients take metformin twice day 3 week surgery . The hypothesis metformin reduce cell proliferation rate ( Ki67 ) increase apoptoses ( TUNEL ) tumor tissue . The study collect analyze pre- post-treatment blood specimen : - Serum glucose - Insulin level - Estradiol - HOMA test - Glycosylated haemoglobin</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Invasive breast cancer T1 T2 , Nx Knowledge investigational nature study ability provide consent study participation Diabetes baseline glucose Glycosylated haemoglobin upper limit normal institution Recent use corticosteroid AST &gt; 1.5 time upper limit normal institution Pregnancy Serious clinical illness Prior concurrent systemic neoadjuvant Breast Cancer therapy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Metformin</keyword>
	<keyword>Pre-Surgery</keyword>
</DOC>